Recent advance of the study on pathogenesis of age-related macular degeneration

International Journal of Ophthalmology

Volumn 8, Issue 9, 2008, Pages 1888-1890

  Yan, Yan ^a   Wang, Ling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Literature review; Pathogenesis

Indexed keywords

LIPOFUSCIN;

ARTICLE; BRUCH MEMBRANE; CELL FUNCTION; CHOROID CAPILLARY LAYER; DISEASE COURSE; ENVIRONMENTAL FACTOR; EYE INFLAMMATION; GENETIC RISK; HUMAN; MEDICAL RESEARCH; METABOLISM; MOLECULAR BIOLOGY; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA CELL; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR;

EID: 54549113350     PISSN: 16725123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tuo J, Bojanowski CM, Chan CC. Genetic factors of age-related macular degeneration. Progr Retin Eye Res 2004;23(2):229-249
2. Traboulsi EI. The challenges and surprises of studying the genetics of age-related macular degeneration. Am J Ophthalmol 2005;139(5): 908-911
3. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123(2):199-206
4. Bok D. Evidence for an inflammatory process in age-related macular degeneration gains new support. Proc Natl Acad Sci USA 2005;102 (20):7053-7054
5. Kuehn BM. Gene discovery provides clues to cause of age-related macular degeneration. JAMA 2005;293(15):1841-1845
6. Beatty S, Koh H, Phil M, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45(2):115-134
7. Age-Related Eye Disease Study Research Group. A randomized, placebocontrolled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119(10): 1417-1436
8. Evans JR, Fletcher AE, Wormald RP. 28,000 Cases of age-related macular degeneration causing visual loss in people aged 75 years and above in the United Kingdom may be attributable to smoking. Br J Ophthalmol 2005;99(5):550-553
9. Thornton J, Edwards R, Mitchell P, et al. Smoking and age-related macular degeneration: a review of association. Eye 2005;19:935-944
10. Mitchell P, Smith W, Wang JJ. Iris color, skin sun sensitivity, and age-related maculopathy: the Blue Mountains Eye Study. Ophthalmology 1998;105(9):1359-1363
11. Margrain TH, Boulton M, Marshall J, et al. Do blue light filters confer protection against age-related macular degeneration? Prog Retin Eye Res 2004;23(5):523-531
12. Reme CE. The dark side of light: rhodopsin and the silent death of vision: the Proctor Lecture. Invest Ophthalmol Vis Sci 2005;46(8):2671-2682
13. Grimm C, Wenzel A, Hafezi F, et al. Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration. Nat Genet 2000;25(1):63-66
14. Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand 2006;84(1):4-15
15. Kim SR, Fishkin N, Kong J, et al. Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci USA 2004;101(32): 11668-11672
16. Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Retin Eye Res 2004;23(5):533-559
17. Sparrow JR, Boulton M: RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 2005;80(5):595-606
18. Warburton S, Southwick K, Hardman RM, et al. Examining the proteins of functional retinal lipofuscin using analysis as a guide for understanding its origin. Mol Vis 2005;11:1122-1134
19. Jiang W, Chiou GCY. The development of age-related macular degeneration (AMD) experiment models. Int J Ophthahnol (Guoji Yanke ZaZhi) 2007;7(3):585-589
20. Crabb JW, Miyagi M, Gu X, et al. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002;99(23):14682-14687
21. Kijlstra A, La Heij EC, Hendrikse F. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul Immunol Inflam 2005;13:3-11
22. Kuehn BM. Gene discovery provides clues to cause of agerelated macular degeneration. JAMA 2005;293:1841-1845
23. Zipfel PF, Heinen S, Jozsi M, et al. Complement and diseases: defective alternative pathway control results in kidney and eye diseases. Mol Immunol 2006;43(1-2):97-106
24. Campochiaro PA. Ocular neovascularization and excessive vascular perineability. Expert Opin Biol Ther 2004;4(9):1395-1402
25. Zhou HW, Wu Q. Vascular endothelial growth factor and its receptors in choroid and retinal neovasculartization. Int J Ophthalmol (Guoji Yanke Zazhi) 2007;7(3):791-795
26. Das A, McGuire PG. Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 2003;22(6):721-748
27. Ng EW, Adamis AP. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 2005;40(3):352-368
28. Sun Y, Yan ZG, Gao H. Pathologic neovascularization and age-related macular degeneration. Int J Ophthalmol (Guoji Yanke Zazhi) 2007;7 (4):1101-1103
29. Zhang X, Ren BC. Recent advance of the study on treatment for age-related macular degeneration. Int J Ophthalmol (Guoji Yanke Zazhi) 2007;7(6):1674-1676